A simple blood or stool test could soon predict colorectal cancer with over 90% accuracy, transforming how we screen for this silent disease.
Explore how DNA methylation biomarkers in liquid biopsies are revolutionizing early detection of colorectal cancer through innovative blood tests.
Exploring the role of ABCC1 and ABCG2 genetic variants in colorectal cancer development, drug resistance, and treatment outcomes.
Discover how the CIITA gene, once suspected in colorectal cancer development, was exonerated through rigorous genetic research and what this means for cancer science.
Discover how the p16 gene is silenced through methylation in colorectal cancer, with surprising differences based on tumor location and gender.